Drawing for GALVOSURGE

USPTO serial 79151856

GALVOSURGE

Reviewed by CopyMark Law Group

Reg. 4805930Status 709
Filing date
Status date
Registration date
Sep 8, 2015
Examiner
CORDOVA, RAUL
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GALVOSURGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lina A. Asmar

Lina A. Asmar L.A. LAW, PLLC24681 Northwestern Hwy, Suite No. 4007Southfield, MI 48075UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Polishes for dentures, bridges and surgical implants; preparations for cleaning dentures, bridges and surgical implants; dental bleaching gels; dentifricesSECTION 71 - CANCELLED—
005Alcohol for pharmaceutical purposes; Analgesic and muscle relaxant pharmaceutical preparations; Antibacterial pharmaceuticals; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Anti-diabetic pharmaceuticals; Balms for pharmaceutical purposes; Bicarbonate of soda for pharmaceutical purposes; Bismuth preparations for pharmaceutical purposes; Bismuth subnitrate for pharmaceutical purposes; Bromine for pharmaceutical purposes; Ferments for pharmaceutical purposes; Flour for pharmaceutical purposes; Frostbite salve for pharmaceutical purposes, Hyaluronic acid for pharmaceutical purposes, Hydrated chioral for pharmaceutical purposes; Iodine for pharmaceutical purposes; Menthol for pharmaceutical purposes; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations for wounds; Pharmaceutical and veterinary preparations, namely, anticoagulants, antidepressants, a blood clotting aid and delivery system for use in human and veterinary medicine; Analgesic for human consumption taken orally; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Sanitary preparations for medical purposes, namely, chemical preparations, disinfectants, napkins, pads, panties, tampons towels; Sanitary preparations for medical use; Food for babies; Dietary supplements for human beings and animals; Medical plasters; dressings for wounds, burns, bandages, gauze, medical and surgical purposes; Teeth filling material and dental impression materials; Disinfectants for sanitary purposes; Preparations for destroying noxious animals; Fungicides; HerbicidesSECTION 71 - CANCELLED—
010Surgical apparatus and instruments for medical, dental or veterinary use; prosthetic limbs, namely, arms, feet; artificial eyes and teeth; orthopedic articles, namely, apparatus and instruments for diagnostic and therapeutic use, belts, braces, cushions and padding, devices for diagnostic and therapeutic use, joint implants made of artificial materials, support bandages, plaster casts; suture materialsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 20, 2026C71TCANCELLED SECTION 71—
Sep 8, 2024REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
May 2, 2024RNWLINTERNATIONAL REGISTRATION RENEWED—
Jun 30, 2022NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jun 30, 202271AGREGISTERED-SEC.71 ACCEPTED—
Jun 7, 2022EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jan 5, 2022PR71POST REGISTRATION ACTION MAILED - SEC.71—
Nov 8, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 1, 2021ES71TEAS SECTION 71 RECEIVED—
Mar 22, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 18, 2016CHLDCHANGE OF OWNER RECEIVED FROM IB—
Feb 27, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 20, 2016XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jan 20, 2016XXCRGENERIC MADRID TRANSACTION CREATED—
Dec 8, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 8, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 23, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2015NPUBNOTICE OF PUBLICATION—
May 18, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 15, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 12, 2015CNEAEXAMINERS AMENDMENT MAILED—
May 12, 2015XAECEXAMINER'S AMENDMENT ENTERED—
May 12, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
May 5, 2015ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 28, 2015PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Apr 11, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 10, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 26, 2015ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 26, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 20, 2015ALIEASSIGNED TO LIE—
Mar 18, 2015MAILPAPER RECEIVED—
Mar 12, 2015MAILPAPER RECEIVED—
Mar 12, 2015FAXXFAX RECEIVED—
Oct 10, 2014RFNTREFUSAL PROCESSED BY IB—
Sep 25, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 25, 2014RFRRREFUSAL PROCESSED BY MPU—
Sep 25, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 24, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 17, 2014DOCKASSIGNED TO EXAMINER—
Sep 17, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 11, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance